Trial Profile
Phase I Study of Post Transplant rhIL-12 High Dose Cyclophosphamide, Thiotepa, and Carboplatin in the Treatment of Metastatic Breast Carcinoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2005
Price :
$35
*
At a glance
- Drugs Interleukin-12 (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 18 Sep 2005 New trial record.